Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2013
09/12/2013WO2013133472A1 Activating transcription factor 3 (atf3) for toxicity prediction and as therapeutic target
09/12/2013WO2013133459A1 Reagent composition for biosensors and biosensor comprising reagent layer formed of the same
09/12/2013WO2013133402A1 Method for detecting single nucleotide polymorphism in nucleic acid
09/12/2013WO2013133393A1 Single-stranded nucleic acid molecule for inhibiting vegf gene expression
09/12/2013WO2013133351A1 Novel fgfr3 fusion product
09/12/2013WO2013133330A1 Plant having suppressed expression of glycoalkaloid biosynthetic enzyme gene or altered activity of the enzyme
09/12/2013WO2013133298A1 Method for detecting inflammatory bowel disease, and method for testing human salivary flora
09/12/2013WO2013133297A1 Method for stimulating t cell and use thereof
09/12/2013WO2013133244A1 High speed gene amplification detection device
09/12/2013WO2013133243A1 Juvenile hormone epoxidase gene and use thereof
09/12/2013WO2013133220A1 Cancer malignancy testing method, pluripotent tumorigenic cells, and preparation method therefor
09/12/2013WO2013133132A1 Method for producing double-stranded dna
09/12/2013WO2013132700A1 Method for detecting target nucleic acid
09/12/2013WO2013132645A1 Nucleic acid amplification method
09/12/2013WO2013132504A1 Assay for the detection of nucleotide substitutions in genomes of sabin oral poliovirus vaccine viruses
09/12/2013WO2013132502A1 Method and kit for the detection of hepatitis-specific antibodies
09/12/2013WO2013132496A1 Methods and kits for the detection of viral infections
09/12/2013WO2013132447A1 Real time pcr detection of m. tuberculosis resistant/susceptible to rifampicin and/or isoniazid
09/12/2013WO2013132443A1 Real-time pcr detection of mycobacterium tuberculosis complex
09/12/2013WO2013132412A1 Use of rbm39 as a biomarker
09/12/2013WO2013132305A1 Size-based analysis of fetal dna fraction in maternal plasma
09/12/2013WO2013132074A2 A genotyping test for assessing risk of autism
09/12/2013WO2013132058A1 Diagnostic chewing gum for pathogens
09/12/2013WO2013132025A1 Mirna based treatment monitoring in multiple sclerosis
09/12/2013WO2013132001A1 Prognostic biomarkers for survival after treatment of a cancer disease with radiotherapy and/or chemotherapy
09/12/2013WO2013131991A1 Means and methods for determining neurotoxin activity based on a modified luciferase
09/12/2013WO2013131981A1 Predictive markers useful in the diagnosis and treatment of fragile x syndrome (fxs)
09/12/2013WO2013131962A1 Improved methods of nucleic acid sequencing
09/12/2013WO2013131933A1 In vitro method for determining disease outcome in pulmonary carcinoids
09/12/2013WO2013131888A1 Cyclic single molecule sequencing process
09/12/2013WO2013131885A1 Compatible solute ectoine as well as derivatives thereof for enzyme stabilization
09/12/2013WO2013131567A1 Mirna based treatment monitoring in multiple sclerosis
09/12/2013WO2013131411A1 Micro-devices for improved disease detection
09/12/2013WO2013131235A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof
09/12/2013WO2013131143A1 Micrornas and uses thereof
09/12/2013WO2013131130A1 Organic thin film transistors and the use thereof in sensing applications
09/12/2013WO2013107460A3 Micrornas for prediction of treatment efficacy and prognosis of cancer patients
09/12/2013WO2013098797A3 Diagnostic tests for predicting prognosis, recurrence, resistance or sensitivity to therapy and metastatic status in cancer
09/12/2013WO2013070796A3 Propeptide-luciferase fusion proteins and methods of use thereof
09/12/2013WO2013067489A9 Nucleic acid-based linkers for detecting and measuring interactions
09/12/2013WO2013006720A3 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b and respiratory syncytial virus
09/12/2013WO2012096873A9 Methods and drug products for treating alzheimer's disease
09/12/2013WO2012078618A3 Predicting and treating diabetic complications
09/12/2013US20130239239 Lmcd1 cancer markers and methods for their use
09/12/2013US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain
09/12/2013US20130237696 Vascular therapeutics
09/12/2013US20130237588 Vascular therapeutics
09/12/2013US20130237586 DELIVERY OF dsRNA TO ARTHROPODS
09/12/2013US20130237520 Imidazopyrazine syk inhibitors
09/12/2013US20130237460 Sensor circuit for controlling, detecting, and measuring a molecular complex
09/12/2013US20130237457 Method of detecting pathogenic legionella strains
09/12/2013US20130237456 Marker consisting of plasma microrna and a new method for diagnosis of hepatocellular carcinoma
09/12/2013US20130237451 Compositions and methods for treatment of protein misfolding diseases
09/12/2013US20130237450 Method for Detecting Nucleic Acids
09/12/2013US20130237449 Usp2a peptides and antibodies
09/12/2013US20130237448 Sugarcane-sugar-yield-related marker and the use thereof
09/12/2013US20130237447 Genetic markers associated with scoliosis and uses thereof
09/12/2013US20130237446 Use of the Genes in the Hog, Ras and cAMP Pathway for Treatment Of Fungal Infection
09/12/2013US20130237445 Methods and kits for detecting melanoma
09/12/2013US20130237444 Gbm molecular contexts associated with patient survival
09/12/2013US20130237442 Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
09/12/2013US20130237441 Mig-6 Knockout Mice and Elucidation of Association of Mig-6 With Early Onset Degenerative Joint Disease and Role As A Tumor Suppressor
09/12/2013US20130237440 Method and means for identification of animal species
09/12/2013US20130237438 Physiogenomic method for predicting statin injury to muscle and muscle side effects
09/12/2013US20130237437 Nucleic acid hybridization probes
09/12/2013US20130237434 Separation of pyrophosphate release and pyrophosphate detection
09/12/2013US20130237432 Application of a pcr sequencing method, based on dna barcoding technique and dna incomplete shearing strategy, in hla genotyping
09/12/2013US20130237431 Size-based analysis of fetal dna fraction in maternal plasma
09/12/2013US20130237429 Discovery and utilization of sorghum genes (ma5/ma6)
09/12/2013US20130237428 Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions
09/12/2013US20130237427 Y-shaped probe and variant thereof, and dna microarray, kit and genetic analysis method using the same
09/12/2013US20130236925 Detection of rate changes in systematic oscillations of metabolic pathways by monitoring isotope ratios
09/12/2013US20130236920 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna
09/12/2013US20130236905 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies
09/12/2013US20130236904 Method for screening for materials for promoting the differentiation of skin cells
09/12/2013US20130236901 Microfluidic device for production and collection of droplets of a fluid
09/12/2013US20130236898 Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES
09/12/2013US20130236897 Anaplasma FAMILY MEMBERS CAUSE A NUMBER OF BLOOD-BORNE DISEASES
09/12/2013US20130236896 E. coli o157:h7 specific assay
09/12/2013US20130236895 Method of sequence determination using sequence tags
09/12/2013US20130236894 Mutations in sptlc2 gene associated with sensory neuropathy
09/12/2013US20130236893 Method of detecting type ii diabetes
09/12/2013US20130236892 Means and methods for the detection of a predisposition of a female subject to recurrent pregnancy loss (rpl), preeclampsia (pe) and/or fetal growth restriction (fgr)
09/12/2013US20130236891 Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells
09/12/2013US20130236890 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells
09/12/2013US20130236886 Phage Phi 29 DNA Polymerase Chimera
09/12/2013US20130236884 Compositions for use in identification of orthopoxviruses
09/12/2013US20130236883 Process of directly detecting and identifying a microorganism in a biological sample diluted in an enrichment broth
09/12/2013US20130236880 Direct detection of unamplified hepatitis c virus rna using unmodified gold nanoparticles
09/12/2013US20130236567 Gene expression signature as a predictor of chemotherapeutic response in breast cancer
09/12/2013US20130236566 Red Blood Cell Dynamics for Diagnosis
09/12/2013US20130236484 Leishmaniasis antigen detection assays and vaccines
09/12/2013US20130236465 Epidermal growth factor receptor variant lacking exon
09/12/2013US20130236450 Methods Using Lipoprotein-Associated Phospholipase A2 in an Acute Care Setting
09/12/2013US20130236441 Methods of treating and preventing thrombotic diseases using ask1 inhibitors
09/12/2013US20130236437 Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases
09/12/2013US20130236404 Substances and compositions for enhancing dna repair and methods of use
09/12/2013US20130233726 Method of correcting for oxygen effect on test sensors
09/12/2013DE102012101885A1 Determining catalytic activity of molecules, involves providing active molecule with biological deiodinase activity, providing substrate compound for molecule, and contacting reaction partners with molecule and substrate under conditions
09/12/2013CA2861054A1 Compatible solute ectoine as well as derivatives thereof for enzyme stabilization